Better Together.
 
															 
															 
															 
															We’re Better Together.
Now including therapies from BIOTRONIK Vascular Intervention (VI), Teleflex is proud to provide you with a portfolio of category-defining technologies for coronary vascular interventions and peripheral vascular interventions—from access and delivery to therapy and closure.
Read the press release.
Coronary Vascular Interventions (CVI)
In the interventional cardiology space, Teleflex has been focused on providing a unique portfolio of products designed to fill gaps in existing technologies and complement physicians’ experience and abilities.
Category-defining products like our GuideLiner™ V3 Guide Extension Catheter, Ringer™ Perfusion Balloon Catheter and Turnpike™ Catheter are just a few examples of this commitment to innovation and engineering.
Now, with the acquisition of BIOTRONIK VI, we’re combining two strong, complementary portfolios—our 
market-leading complex catheters and BIOTRONIK VI’s differentiated percutaneous coronary intervention (PCI) balloon and stent technologies, such as the Orsiro™ Mission™ Drug-Eluting Stent,
PK Payprus™ Covered Coronary Stent**, and the Pantera™ LEO Non-Compliant Balloon Catheter.
Together, we’re helping simplify the procedural challenges you face every day—
from access and delivery to therapy and closure.  
								Guide Extension 
Catheters							
						
													GuideLiner™ Coast™ Catheters
Microcatheters
Each catheter in the Turnpike™ Catheter portfolio contains specific design elements to address various clinical challenges.
The Twin-Pass™ Dual Access Catheters offer the convenience of an over-the-wire lumen and a rapid exchange lumen in a single catheter.
Balloon Catheters
the Pantera™ Pro Semi-Compliant Balloon Catheter offers better crossability1, 43% less friction1,2 during simultaneous use, and 38% more pushability1,3.
Indicated for stent post-dilatation and dilatation of a coronary artery or bypass graft stenosis, the Pantera™ LEO Non-Compliant Balloon Catheter design features the lowest compliance in its class1,4 and ehanced crossability1 .
								Ultrathin Strut* 
Drug-Eluting Stent							
						
													Drug-Eluting Stent
patient outcomes8.
*Nominal strut thickness for size ø 2.25 - 3.0 mm, mean diameter 62 μm.
								Perfusion Balloon 
Catheter							
						
													Balloon Catheter
In addition, during PTCA the lumen serves as a passage for delivery of secondary devices creating new opportunities for procedural innovation.
Covered Stent
Covered Coronary Stent**
** Humanitarian Device. Authorized by Federal law for use in the treatment of acute perforations of native coronary arteries and coronary bypass grafts in vessels 2.5 to 5.0 mm in diameter. The effectiveness of this device for this use has not been demonstrated.
Peripheral Vascular Interventions (PVI)
With a global incidence of 200 million and more than 8 million people in the US, Peripheral Arterial Disease is a leading cause of adverse limb events9, yet it remains underdiagnosed and therefore, undertreated10. 
Several of Teleflex’s  coronary products—like our Specialty Guidewires, GuideLiner™ V3 Catheter, and SuperCross™ Microcatheters—are also indicated for use in the peripheral vasculature. The Teleflex acquisition of BIOTRONIK VI brings innovative PCI balloon and stent technologies—such as a peripheral balloon portfolio 
with a wide range to dilate stenosis and the Pulsar™-18 T3 Self-Expanding Stent System—to round out our offerings for PCI procedures.
Together, we’re providing physicians with more options for treating their patients—
from access and delivery to therapy and closure.
Introducers
Sheath System and
Super Arrow-Flex™ Sheaths
Super Arrow-Flex™ Sheaths are designed to deliver optimal performance from start to finish. With a wide range of sheath sizes and lengths, the sheaths provide various choices for multiple vascular applications.
Specialty Guidewires
Raider™, and Warrior™ Guidewires
designed to tackle a variety of situations
in complex cases.
When you choose from the Teleflex portfolio, you choose guidewires made to work with and for you — so you can adapt to a broad range of challenges.
Microcatheters
The uniquely constructed Turnpike™ Catheter contains a robust multi-layer shaft that provides impressive flexibility, torque transmission and tracking over a 0.014” guidewire in complex coronary and peripheral interventions.
The Twin-Pass™ Dual Access Catheters offer the convenience of an over-the-wire lumen and a rapid exchange lumen in a single catheter.
Percutaneous Transluminal Angioplasty (PTA) Balloons
and Passeo™-35 Xeo™
PTA Balloon Catheters
A low-profile PTA balloon, the Passeo™-18 PTA Balloon Catheter features high pushability and controlled compliance.
The Passeo™-35 Xeo™ PTA Balloon Catheter, another low-profile PTA balloon, offers excellent deliverability in a wide range of sizes.
Self-Expanding Stent Systems
Self-Expanding Stent Systems
A unique combination of three technologies, the Pulsar™-18 T3 Self-Expanding Stent System features thin struts and low Chronic Outward Force, a low profile delivery system, and a tri-axial system with braided shaft for accurate
stent deployment.
Hemostasis
& QuikClot™ Radial™
Hemostatic Dressings
This bleeding control solution has lower mean time to hemostasis* 14,
and may help improve patient throughput in the cath lab14.
Teleflex Academy
 
															Education the Teleflex Way
Teleflex Academy programs are designed to reinforce clinical fundamentals, build new skills, and promote best practices for optimal patient outcomes.
myTeleflex
 
															*Orsiro™ Mission™ DES has a nominal strut thickness for size ø 2.25 – 3.0 mm, mean diameter 62 μm.
**The PK Papyrus™ Covered Coronary Stent is a Humanitarian Device. Authorized by Federal law for use in the treatment of acute perforations of native coronary arteries and coronary bypass grafts in vessels 2.5 to 5.0 mm in diameter. The effectiveness of this device for this use has not been demonstrated.
***Compared to standard gauze. Time to hemostasis was defined as the time from the start of compression to the time at which no further compression was required to control bleeding at the arteriotomy site.
REFERENCES:
- Data on file at Teleflex. Test data may not be indicative of clinical performance;
- Bench test with 3.0/20mm size when compared to Trek;
- Bench test with 1.5/15mm size when compared to Mini Trek;
- When compared to NC Emerge, NC Euphora, NC Quantum, NC Sprinter, compliance curves 3.0 mm balloons; c. NP-RBP growth for 3.0 diameters. Leading competitors have been selected based on the PTCA Balloon Catheter Revenue Market Shares US, 2016; (Source: Milennium Research Group Inc.). Latest NC balloons for each competitor;
- In comparison to Xience Sierra, Resolute Onyx and Synergy for bench tests on pushability, trackability and crossability;
- As characterized with respect to strut thickness in Bangalore et al. Meta-analysis, Circulation. 2018 Nov 13;138(20):2216-2226;
- Per investigators’ interpretation in Secco et al. Imaging data serial observations. Secco GG et al. Time-related changes in neointimal tissue coverage of a novel Sirolimus eluting stent: Serial observations with optical coherence tomography. Cardiovascular Revascularization Medicine. 2016; 17(1): 38-43;
- Based on investigator’s interpretation of BIOFLOW-V primary endpoint result;
- Trabattoni D, Montorsi P, Fabbiocchi F, et al. Eur Radiol. 2011; 21: 1687-1691. Pre-clinical study. Test data may not be indicative of clinical performance;
- Griffin J.H. Natl Acad Sci U S A. 1978 Apr; 75(4): 1998 -2002. Pre-clinical study. Test data may not be indicative of clinical performance;
- Margolis J. Journal Clin Pathol 1958; 11: 406-409. Pre-clinical study. Test data may not be indicative of clinical performance;
- Roberts JS, Nau J, Pastor-Cervantes JA. J Invasive Cardiol. 2017; 29: 328-334. Research sponsored by Teleflex. Test data may not be indicative of clinical performance;
- Thomas, V and Beckman, J. Racial and Socioeconomic Health Disparities in Peripheral Artery Disease. Journal of the American Heart Association. 2024 Nov https://doi.org/10.1161/JAHA.123.031446;
- Jones WS, Patel MR, Dai D, Vemulapalli S, Subherwal S, Stafford J, Peterson ED. High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. Am Heart J. 2013 May;165(5):809-15, 815.e1. doi: 10.1016/j.ahj.2012.12.002. Epub 2013 Feb 5. PMID: 23622919.
CAUTION: Federal (USA) law restricts these devices to sale or use by or on the order of a physician.
Refer to this IFU link for a copy of the Instructions for Use and for a complete listing of the indications, contraindications, warnings and precautions. Information in this material is not a substitute for the product Instructions for Use. Not all products may be available in all countries. Please contact your local representative.
Teleflex, the Teleflex logo, Astron, Bandit, Coast, Fortress, GuideLiner, Interventional, Mission, Orsiro, Orsiro Mission, Pantera, Passeo, PK Papyrus, Pulsar, QuikClot, R350, Radial, Raider, Ringer, Spectre, Super Arrow-Flex, SuperCross, Turnpike, Twin-Pass, Warrior, and Xeo are trademarks or registered trademarks of Teleflex Incorporated or its affiliates in the U.S. and/or other countries. BIOTRONIK is a registered trademark of Biotronik SE & Co.
© 2025 Teleflex Incorporated. All rights reserved. MC- 011156 Rev 0. Revised 10/2025.


